Moderna is applying for an Emergency Use Authorization from the US Food and Drug Administration for its SARS-CoV-2 vaccine, the New York Times reports.
Moderna is applying for an Emergency Use Authorization from the US Food and Drug Administration for its SARS-CoV-2 vaccine, the New York Times reports.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.